CGEM
Cullinan Therapeutics, Inc.After hours14.10−0.85 −5.69%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 14.10 0.00%
Open
14.86
Prev close
14.95
Day range
14.0814.93
52-week range
6.7323.19
Volume
590.35K0.67×
Mkt cap
866.56M
P/E ttm
—
Fwd P/E
-5.60
EPS ttm
-3.11
Div yield
0.00%
Earnings
Nov 14, 2026
From 52w high
−39.20%
CGEM shareholders
CGEM Ownership
13F / N-PORT filings via Yahoo
Institutions
112.6%
113.1% of the float
Insiders
0.4%
officers and directors
Institutional holders
252
filing positions
Top 10 institutions
73.3%
7 adding · 0 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| MPM Bioimpact LLC | 15.12% | 9.73M | $137.21M | +27.2% | Jun 30, 2026 |
| Lynx1 Capital Management Lp | 13.93% | 8.96M | $126.39M | 0.0% | Jun 30, 2026 |
| BVF Inc. | 8.94% | 5.75M | $81.08M | 0.0% | Jun 30, 2026 |
| Blackrock Inc. | 8.13% | 5.23M | $73.78M | +17.6% | Jun 30, 2026 |
| Price (T.Rowe) Associates Inc | 5.95% | 3.83M | $53.95M | +88.5% | Jun 30, 2026 |
| State Street Corporation | 5.70% | 3.67M | $51.73M | +44.2% | Jun 30, 2026 |
| Kynam Capital Management, LP | 4.84% | 3.11M | $43.91M | 0.0% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 4.06% | 2.61M | $36.86M | +5.3% | Jun 30, 2026 |
| RTW Investments LP | 3.67% | 2.36M | $33.34M | +38.6% | Jun 30, 2026 |
| Siren, L.L.C. | 2.94% | 1.89M | $26.70M | +58.7% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.90% | 2.51M | $35.39M | +7.5% | Aug 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 1.93M | $27.21M | +4.0% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.42% | 1.55M | $21.91M | +0.7% | Aug 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.58% | 1.02M | $14.37M | +140.4% | Jun 30, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.03% | 660.99K | $9.32M | +0.8% | Jul 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.97% | 621.22K | $8.76M | +9.0% | Jun 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.91% | 583.80K | $8.23M | −15.0% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 Value ETF | 0.88% | 564.85K | $7.96M | +0.5% | Aug 31, 2026 |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 0.87% | 559.80K | $7.89M | +88.0% | Jun 30, 2026 |
| TR PRICE-Price (T.Rowe) New Horizons Trust | 0.70% | 452.66K | $6.38M | +129.4% | Jun 30, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).